MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/eja.0000000000001634

Медицинская библиотека · European journal of anaesthesiology · 2022

Neonatal outcomes following prophylactic administration of phenylephrine or noradrenaline in women undergoing scheduled caesarean delivery: A randomised clinical trial.

Singh Apoorva, Jain Kajal, Goel Nitika, Arora Aashima, Kumar Praveen

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

There is limited evidence to support the use of noradrenaline over phenylephrine during elective caesarean section with regards to its impact on foetal acidosis. Concerns regarding a deleterious effect of noradrenaline on foetal blood gas analysis because of its β-mimetic activity cannot currently be ruled out by data from randomised controlled trials.

OBJECTIVE

We hypothesised that noradrenaline would be associated with higher umbilical artery base excess values and less foetal acidosis compared with phenylephrine. This study aimed to observe the effect of prophylactic infusions of phenylephrine or noradrenaline in low-risk elective caesarean delivery on umbilical artery blood gas analysis.

DESIGN

A prospective, randomised, double-blind trial.

SETTING

Labour room operating theatre of tertiary care hospital in Northern India from April 2020 to November 2020.

PATIENTS: Full-term, nonlabouring pregnant women, scheduled for elective caesarean delivery under spinal anaesthesia.

INTERVENTION: Equipotent prophylactic infusions of either phenylephrine 100 μg min-1 or noradrenaline 5 μg min-1 were administered to maintain maternal SBP between 90 and 110% of baseline using a predefined algorithm.

MAIN OUTCOME MEASURE: The primary outcome was umbilical artery base excess in noradrenaline versus the phenylephrine group. The incidence of foetal acidosis defined as umbilical artery base excess less than -6 mmol l-1 was also assessed for noradrenaline versus phenylephrine.

RESULTS

Median [IQR] umbilical artery base excess was significantly higher in the noradrenaline group: -5.4 [-6.6 to -4.03] versus -6.95 [-9.02 to -4.53] in the phenylephrine group (P = 0.014). No significant difference in the incidence of foetal acidosis was observed between noradrenaline and phenylephrine groups: 36 versus 54% (P 0.07); difference 18% (95% CI, -1.4 to 35.6%).

CONCLUSION

Prophylactic noradrenaline 5 μg min-1 infusion resulted in higher base excess values compared with phenylephrine 100 μg min-1 infusion. A comparable incidence of foetal acidosis was observed in women receiving either noradrenaline or phenylephrine. Maternal bradycardia was more pronounced with phenylephrine while targeting blood pressure goals.

CTRI: CTRI/2020/03/023986.

Для цитирования: Singh Apoorva, Jain Kajal, Goel Nitika, Arora Aashima, Kumar Praveen. Neonatal outcomes following prophylactic administration of phenylephrine or noradrenaline in women undergoing scheduled caesarean delivery: A randomised clinical trial.. European journal of anaesthesiology. 2022. DOI: 10.1097/eja.0000000000001634.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.